• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原因不明的出血性疾病妇女妊娠结局与处理。

Outcomes and management of pregnancy in women with bleeding disorder of unknown cause.

机构信息

Haemophilia Centre, University Hospital of Wales, Cardiff, UK.

Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

出版信息

J Thromb Haemost. 2022 Nov;20(11):2519-2525. doi: 10.1111/jth.15871. Epub 2022 Sep 21.

DOI:10.1111/jth.15871
PMID:36053176
Abstract

BACKGROUND

Patients with a bleeding tendency with normal laboratory tests have been described as having an unclassified bleeding disorder or bleeding disorder of unknown cause (BDUC). There are very little data available on how to manage pregnancy.

OBJECTIVES

To study management and outcomes of these patients at four United Kingdom hemophilia comprehensive care centers.

METHODS

Retrospective case note review from 2010-2020.

RESULTS

Sixty deliveries in 36 patients were recorded. The median International Society on Thrombosis and Haemostasis bleeding assessment tool score was 9. In 54 cases for which data were available, the odds ratio for post partum hemorrhage (PPH) was 6.3 for no primary hemostatic prophylaxis versus prophylaxis (95% confidence interval 1.2-34.2, p < .05); 7/9 (78%) versus 16/45 (36%) PPH incidence for the groups, respectively. Hemostatic prophylaxis was with tranexamic acid but some patients received desmopressin or platelet infusions. Secondary PPH was seen in 5/60 (8%) of cases. No neonatal bleeding complications or maternal thromboembolic complications were noted. Avoidance of regional anesthesia and fetal delivery precautions were commonly advised, but in the small number of cases in which they occurred no complications were noted.

CONCLUSIONS

Despite hemostatic prophylaxis PPH was commonly seen. Further prospective studies of BDUC patients are required to determine optimal management in pregnancy as well as determine the pathophysiological basis of bleeding.

摘要

背景

实验室检查正常但存在出血倾向的患者被描述为患有未分类出血性疾病或不明原因出血性疾病(BDUC)。关于如何管理妊娠,数据非常有限。

目的

研究英国四家血友病综合护理中心的这些患者的管理和结局。

方法

回顾性病例记录审查,时间为 2010 年至 2020 年。

结果

记录了 36 名患者中的 60 次分娩。国际血栓与止血学会出血评估工具评分中位数为 9 分。在 54 例可获得数据的情况下,无原发性止血预防与预防相比(95%置信区间为 1.2-34.2,p<0.05),产后出血(PPH)的比值比为 6.3;分别为两组的 7/9(78%)和 16/45(36%)的 PPH 发生率。止血预防使用氨甲环酸,但部分患者接受了去氨加压素或血小板输注。5/60(8%)的病例出现继发性 PPH。未观察到新生儿出血并发症或母体血栓栓塞并发症。通常建议避免区域麻醉和胎儿分娩预防措施,但在发生这些并发症的少数情况下,未观察到并发症。

结论

尽管进行了止血预防,但仍常见 PPH。需要对 BDUC 患者进行进一步的前瞻性研究,以确定妊娠期间的最佳管理方法,并确定出血的病理生理学基础。

相似文献

1
Outcomes and management of pregnancy in women with bleeding disorder of unknown cause.原因不明的出血性疾病妇女妊娠结局与处理。
J Thromb Haemost. 2022 Nov;20(11):2519-2525. doi: 10.1111/jth.15871. Epub 2022 Sep 21.
2
Non-surgical interventions for treating heavy menstrual bleeding (menorrhagia) in women with bleeding disorders.对患有出血性疾病的女性进行非手术干预以治疗月经过多(月经过多)。
Cochrane Database Syst Rev. 2016 Nov 10;11(11):CD010338. doi: 10.1002/14651858.CD010338.pub3.
3
Non-surgical interventions for treating heavy menstrual bleeding (menorrhagia) in women with bleeding disorders.针对患有出血性疾病的女性治疗月经过多(月经过多)的非手术干预措施。
Cochrane Database Syst Rev. 2014 Nov 26(11):CD010338. doi: 10.1002/14651858.CD010338.pub2.
4
Management of surgery, menorrhagia and child-birth for patients with unclassified bleeding disorders: a systematic review of cohort studies.未分类出血性疾病患者的手术、月经过多和分娩管理:队列研究的系统评价。
Blood Coagul Fibrinolysis. 2021 Sep 1;32(6):366-372. doi: 10.1097/MBC.0000000000001045.
5
Periprocedural hemostatic prophylaxis and outcomes in bleeding disorder of unknown cause.不明原因出血性疾病围手术期止血预防及结果
Res Pract Thromb Haemost. 2024 Sep 16;8(7):102572. doi: 10.1016/j.rpth.2024.102572. eCollection 2024 Oct.
6
Maternal and neonatal bleeding complications in relation to peripartum management in hemophilia carriers: A systematic review.携带者围产期管理相关的母婴出血并发症:系统评价。
Blood Rev. 2021 Sep;49:100826. doi: 10.1016/j.blre.2021.100826. Epub 2021 Mar 20.
7
Current practice and registration patterns among United Kingdom Haemophilia Centre Doctors' Organisation centers for patients with unclassified bleeding disorders.英国血友病中心医生组织中心对未分类出血性疾病患者的当前实践和登记模式。
J Thromb Haemost. 2021 Nov;19(11):2738-2743. doi: 10.1111/jth.15492. Epub 2021 Aug 25.
8
Outcome of Surgical Interventions and Deliveries in Patients with Bleeding of Unknown Cause: An Observational Study.不明原因出血患者的手术干预和分娩结局:一项观察性研究。
Thromb Haemost. 2021 Nov;121(11):1409-1416. doi: 10.1055/s-0041-1726344. Epub 2021 Apr 14.
9
High prevalence of postpartum hemorrhage in women with rare bleeding disorders in the Netherlands: retrospective data from the RBiN study.荷兰罕见性出血性疾病女性产后出血发生率较高:RBiN 研究的回顾性数据。
J Thromb Haemost. 2023 Mar;21(3):499-512. doi: 10.1016/j.jtha.2022.11.009. Epub 2022 Dec 22.
10
Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: study protocol for an international, randomised, double-blind, placebo-controlled trial.氨甲环酸预防贫血女性产后出血:一项国际随机双盲安慰剂对照试验的研究方案
Trials. 2018 Dec 29;19(1):712. doi: 10.1186/s13063-018-3081-x.

引用本文的文献

1
[Bleeding disorders of unknown cause : Definition, diagnostics and management in the perioperative and periprocedural setting].[不明原因出血性疾病:围手术期和围操作期的定义、诊断与管理]
Anaesthesiologie. 2025 Aug;74(8):540-550. doi: 10.1007/s00101-025-01558-x.
2
Genomic testing for bleeding disorders (GT4BD): protocol for a randomised controlled trial evaluating the introduction of whole genome sequencing early in the diagnostic pathway for patients with inherited bleeding disorders as compared with standard of care.遗传性出血性疾病的基因组检测(GT4BD):一项随机对照试验的方案,该试验旨在评估与标准治疗相比,在遗传性出血性疾病患者诊断流程早期引入全基因组测序的效果。
BMJ Open. 2025 Apr 17;15(4):e102041. doi: 10.1136/bmjopen-2025-102041.
3
A high HEMSTOP bleeding score is a major independent risk factor for postpartum hemorrhage: a prospective cohort study.高HEMSTOP出血评分是产后出血的主要独立危险因素:一项前瞻性队列研究。
BMC Pregnancy Childbirth. 2025 Feb 14;25(1):165. doi: 10.1186/s12884-025-07281-0.
4
How to treat patients with bleeding disorder of unknown cause?如何治疗病因不明的出血性疾病患者?
Res Pract Thromb Haemost. 2024 Oct 9;8(7):102585. doi: 10.1016/j.rpth.2024.102585. eCollection 2024 Oct.
5
Periprocedural hemostatic prophylaxis and outcomes in bleeding disorder of unknown cause.不明原因出血性疾病围手术期止血预防及结果
Res Pract Thromb Haemost. 2024 Sep 16;8(7):102572. doi: 10.1016/j.rpth.2024.102572. eCollection 2024 Oct.
6
Investigating patients for bleeding disorders when most of the "usual" ones have been ruled out.当大多数“常见”的出血性疾病被排除后,对患者进行出血性疾病的调查。
Res Pract Thromb Haemost. 2023 Oct 30;7(8):102242. doi: 10.1016/j.rpth.2023.102242. eCollection 2023 Nov.